| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1303739a2c7edab095c91e3a226cc45 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2019-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_788c65a65e8af422c0b62abbc04b0715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31bf9ef8611530304a12843fbef0521b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b855b1249de17f0c93a2894f762a2cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc1dc23856c8341c06610bcd14ca098f |
| publicationDate |
2020-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200140377-A |
| titleOfInvention |
New small active RNA |
| abstract |
The present invention provides saRNA. The saRNA consists of a first oligonucleotide strand having 17 to 30 nucleotides and a second oligonucleotide strand having 17 to 30 nucleotides. Sequences of at least 15 nucleotides in length are complementary within the two oligonucleotide strands and the unpaired terminal nucleotides form an overhang. The first oligonucleotide strand or the second nucleotide strand has 75% or more homology or complementarity with any one of a continuous fragment of 16 to 35 nucleotides in length in the promoter of the target gene. The second oligonucleotide strand has an overhang composed of 1 to 4 nucleotides at the 3'end. The saRNA of the present invention can more effectively up-regulate target gene expression while reducing non-target effects. |
| priorityDate |
2018-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |